Wellington Shields Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-968
Closed -$27K 330
2022
Q4
$27K Buy
+968
New +$24.8K ﹤0.01% 290
2022
Q3
Sell
-968
Closed -$33K 311
2022
Q2
$33K Sell
968
-30
-3% -$1.05K ﹤0.01% 281
2022
Q1
$35K Buy
+998
New +$34.1K ﹤0.01% 301

Other funds holding OGN

Wellington Shields Capital Management's OGN Position: Q1 2023 in Review

Wellington Shields Capital Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 968 shares — an estimated $27K sold.

Wellington Shields Capital Management first reported a position in OGN in Q1 2022 and held it in 3 quarters. The position peaked at $35K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Wellington Shields Capital Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Wellington Shields Capital Management sold 968 Organon & Co shares in Q1 2023, an estimated $27K.
  • Wellington Shields Capital Management first reported a position in Organon & Co in Q1 2022 and held it in 3 quarters.
  • Wellington Shields Capital Management's Organon & Co position peaked at $35K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Wellington Shields Capital Management's 13F filing for Q1 2023, filed 11 May 2023.